Pulmonx
LUNG
118 hedge funds and large institutions have $321M invested in Pulmonx in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 22 closing their positions.
55% more call options, than puts
Call options by funds: $17K | Put options by funds: $11K
3.48% less ownership
Funds ownership: 93.45% → 89.97% (-3.5%)
4% less funds holding
Funds holding: 123 → 118 (-5)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
21% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 43
30% less capital invested
Capital invested by funds: $456M → $321M (-$135M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.7M |
| 3 |
JP Morgan Chase
New York
|
+$2.49M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$2.34M |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$2.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$22.3M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$14.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.66M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.65M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.24M |
LUNG Hedge Fund Activity: Q1 2024 in Review
118 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q1 2024, worth a combined $321M — down 30% from $456M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of LUNG and 18 opened new positions — a net loss of 4 holders — while 43 trimmed existing stakes and 34 added.
The largest buyer was Fidelity Investments, adding an estimated $18.1M. The largest seller was Morgan Stanley, cutting an estimated $22.3M.
- 118 institutional investors held Pulmonx (LUNG) as of Q1 2024, down from 123 in Q4 2023.
- Funds reported $321M of Pulmonx stock for Q1 2024, down 30% quarter-over-quarter.
- 18 funds opened new Pulmonx positions in Q1 2024 and 22 closed out, a net change of -4 holders.
- The largest Pulmonx buyer in Q1 2024 was Fidelity Investments, an estimated $18.1M added.
- The largest Pulmonx seller in Q1 2024 was Morgan Stanley, an estimated $22.3M sold.
Based on aggregated 13F filings for Q1 2024.